Angioplasty And stenting For symptomatic intracranial atherosclerotic disease: How I Do It

Ermias A Mekonnen1, Wondwossen G Tekle1,2, Sohum K Desai1,2

  • 1Department of Neuroscience, Valley Baptist Medical Center, Harlingen, TX, USA.

Insights

Intracranial atherosclerotic disease (ICAD) causes recurrent strokes. Recent studies show Balloon-mounted stents (BMS) offer a safer endovascular treatment option for symptomatic ICAD, with lower complication rates than previous trials.

Area of Science:

  • Neurology
  • Vascular Medicine
  • Interventional Cardiology

Background:

  • Intracranial atherosclerotic disease (ICAD) is a significant cause of ischemic stroke.
  • High rates of recurrent stroke occur despite optimal medical management.
  • Endovascular treatment for ICAD remains controversial due to historical complication rates.

Purpose of the Study:

  • To review the recent advancements in endovascular therapy for symptomatic ICAD.
  • To evaluate the safety and efficacy of newer endovascular techniques.

Main Methods:

  • Review of recent multicenter prospective studies on stent placement for ICAD.
  • Comparison of periprocedural complication rates with historical trials (SAMMPRIS, VISSIT).
  • Focus on Balloon-mounted stents (BMS) in symptomatic high-grade intracranial stenosis.

Main Results:

  • A recent prospective study demonstrated significantly lower periprocedural stroke rates (5.6%) with BMS compared to historical trials (SAMMPRIS: 14.7%, VISSIT: 21.4%).
  • This suggests improved safety profiles for contemporary endovascular approaches.
  • Balloon-mounted stents show promise in managing symptomatic ICAD.

Conclusions:

  • Endovascular therapy for symptomatic ICAD has evolved, offering improved safety.
  • Balloon-mounted stents represent a viable and potentially safer option for selected ICAD patients.
  • Further research and clinical adoption of refined endovascular techniques are warranted.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
43
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
49
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
38
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
39
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42